PSTX — Poseida Therapeutics Share News
0.000.00%
Last trade - 00:00- $927.88m
- $755.94m
- $64.70m
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida (updated)
Brief: Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer
U.S. STOCKS ON THE MOVE-Pinterest, Best Buy, Chevron
Poseida Therapeutics surges on Roche's $1.5 bln buyout
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Rivian, Wells Fargo, Woodward
U.S. STOCKS ON THE MOVE-Everest, Zoom, Semtech
Brief: Poseida Therapeutics To Pay Roche Holdings Termination Fee Of $33.42 Million If Deal Is Terminated Under Certain Conditions
Newscasts - Europe Today: European automakers falter after Trump's tariff pledges
Deals of the day-Mergers and acquisitions
Poseida Therapeutics more than triples on Roche's $1.5 bln buyout
Roche to acquire US firm Poseida Therapeutics in $1.5 bln deal (updated)
Roche to acquire US-based Poseida Therapeutics
Poseida Therapeutics Inc reports results for the quarter - Earnings Summary
Poseida Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Poseida Therapeutics Announces Nomination Of New Car-T Development Candidate Under Collaboration With Roche
Brief: Poseida Therapeutics Presents New Case Study